Agreement signedAgreed 24 Aug 2025

MannKind Corporation /
scPharmaceuticals Inc.

MannKind Corporation agrees to buy scPharmaceuticals Inc.

Buy side: MannKind Corporation
Buy sideMannKind Corporation
Target: scPharmaceuticals Inc.
TargetscPharmaceuticals Inc.
MannKind Corporation · 24 Aug 2025Source
Buy side: MannKind Corporation
Buy sideMannKind Corporation
Target: scPharmaceuticals Inc.
TargetscPharmaceuticals Inc.
01 / BuyerMannKind Corporation
02 / TargetscPharmaceuticals Inc.
Source for the buyer and target: MannKind Corporation

For the buyer and target.

“As previously disclosed in the Current Report on Form 8-K filed with the Securities and Exchange Commission (“ SEC ”) by MannKind Corporation, a Delaware corporation (the “ Company ”) on August 25, 2025, the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), dated as of August 24, 2025, with Seacoast Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“ Purchaser ”), and scPharmaceuticals Inc., a Delaware corporation (“ scPharma ”).”

Published 9 Oct 2025

Open the source
01

What happened

MannKind Corporation agreed to acquire scPharmaceuticals Inc. for approximately $296.5 million, according to a filing dated Oct. 9, 2025. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · MannKind Corporation

MannKind Corporation agrees to buy scPharmaceuticals Inc.

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by MannKind Corporation

    The source this page is built from.

    Open the source
  2. Announced

    “MannKind Corporation agrees to buy scPharmaceuticals Inc. MannKind Corporation agreed to acquire scPharmaceuticals Inc. for approximately $296.5 million, according to a filing dated Oct. 9, 2025”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.